Who is the manufacturer of SmartLinx Vitals Plus Patient Monitoring System?

Capsule Technologie Sas filed the 510(k) submission for SmartLinx Vitals Plus Patient Monitoring System (K151071).

What is the FDA product code for SmartLinx Vitals Plus Patient Monitoring System?

MWI. It is classified under 21 CFR 870.2300 as a Class 2 device in the Cardiovascular panel.

What is the regulatory pathway for SmartLinx Vitals Plus Patient Monitoring System?

510(k) clearance (submission type: Traditional).

Who can help prepare an FDA 510(k) submission like SmartLinx Vitals Plus Patient Monitoring System?

Innolitics — a medical-device software consultancy — provides regulatory and engineering support for FDA 510(k) submissions. See https://innolitics.com/services/510ks/ or contact https://innolitics.com/contact.

SmartLinx Vitals Plus Patient Monitoring System

Q: What are the predicate devices for SmartLinx Vitals Plus Patient Monitoring System?

GE Carescape V100 Vital Signs Monitor (K102426).

K151071 · Capsule Technologie Sas · MWI · Sep 17, 2015 · Cardiovascular

Device Facts

Record ID	K151071
Device Name	SmartLinx Vitals Plus Patient Monitoring System
Applicant	Capsule Technologie Sas
Product Code	MWI · Cardiovascular
Decision Date	Sep 17, 2015
Decision	SESE
Submission Type	Traditional
Regulation	21 CFR 870.2300
Device Class	Class 2
Attributes	Pediatric

Indications for Use

The SmartLinx Vitals Plus Patient Monitoring System is intended for monitoring physiologic parameters, including non-invasive blood pressure (systolic, diastolic, and mean arterial pressure), pulse rate, functional arterial oxygen saturation (SpO2), and temperature, on adult, pediatric, and neonatal patients in healthcare facilities when used by clinical physicians or appropriate medical staff under the direction of physicians.

Device Story

System monitors physiologic parameters (NIBP, pulse rate, SpO2, temperature) at point of care; utilizes SmartLinx Neuron 2 mobile platform (Windows-based PC architecture) to interface with integrated modules: SunTech Advantage A+ NIBP module, Masimo SET uSpO2 cable, and Exergen TAT-5000S infrared thermometer. Application software on Neuron 2 platform provides command/control of modules, collects data, and presents vital signs to healthcare providers for active monitoring. System includes roll stand for mobility. Used by clinicians in healthcare facilities to support clinical decision-making through real-time patient data visualization.

Clinical Evidence

Bench testing and clinical performance testing conducted. Clinical performance testing performed in accordance with ISO 81060-2:2013. Results indicated the system complies with predetermined specifications. No animal testing performed.

Technological Characteristics

Platform: SmartLinx Neuron 2 (Windows OS, PC architecture, touchscreen, serial/USB/network/Bluetooth). Modules: SunTech Advantage A+ (oscillometric NIBP), Masimo SET (SpO2), Exergen TAT-5000S (infrared). Power: 12.6V Li-ion battery. Standards: IEC 60601-1, IEC 60601-1-6, IEC 60601-1-8, ISO 80601-2-56, ISO 80601-2-61, ISO 81060-2, IEC 62304, IEC 62366, IEC 62133, IEC 60601-1-2.

Indications for Use

Indicated for monitoring physiologic parameters (NIBP, pulse rate, SpO2, temperature) in adult, pediatric, and neonatal patients within healthcare facilities.

Regulatory Classification

Identification

A cardiac monitor (including cardiotachometer and rate alarm) is a device used to measure the heart rate from an analog signal produced by an electrocardiograph, vectorcardiograph, or blood pressure monitor. This device may sound an alarm when the heart rate falls outside preset upper and lower limits.

Predicate Devices

GE Carescape V100 Vital Signs Monitor (K102426)

Reference Devices

Zoll R Series Monitor Defibrillators (K120907)
Masimo uSpO2 Pulse Oximetry Cable (K121914)
Exergen TAT-5000S (K011291)

Submission Summary (Full Text)

{0}------------------------------------------------ Image /page/0/Picture/1 description: The image shows the logo for the Department of Health & Human Services - USA. The logo features a stylized image of three human profiles facing right, stacked on top of each other. The profiles are black and have a flowing, ribbon-like design at the bottom. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES-USA" is arranged in a circular pattern around the image. Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002 Capsule Technologie SAS Peter Kelley Director of QA/RA 300 Brickstone Square, Suite 203 Andover, Massachusetts 01810 Re: K151071 Trade/Device Name: SmartLinx Vitals Plus Patient Monitoring System Regulation Number: 21 CFR 870.2300 Regulation Name: Cardiac Monitor (Including Cardiotachometer And Rate Alarm) Regulatory Class: Class II Product Code: MWI Dated: August 5, 2015 Received: August 12, 2015 Dear Peter Kelley: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration. Iisting of devices. good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR {1}------------------------------------------------ Part 807); labeling (21 CFR Part 801); medical device reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Sincerely yours, Mitchell Stein for Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ Indications for Use 510(k) Number (if known): Device Name: SmartLinx Vitals Plus Patient Monitoring System Indications for Use: The SmartLinx Vitals Plus Patient Monitoring System is intended for monitoring physiologic parameters, including non-invasive blood pressure (systolic, diastolic, and mean arterial pressure), pulse rate, functional arterial oxygen saturation (SpO2), and temperature, on adult, pediatric, and neonatal patients in healthcare facilities when used by clinical physicians or appropriate medical staff under the direction of physicians | Prescription Use | X | |-----------------------------|------------------------| | | AND/OR | | Over-The-Counter Use | | | (Part 21 CFR 801 Subpart D) | (21 CFR 801 Subpart C) | (PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) {3}------------------------------------------------ | Submitter | Capsule Technologie SAS 9 villa Pierre Ginier 75018 Paris, FR | |---------------------|----------------------------------------------------------------------------------------------------------------------------------------------| | Contact Person | Peter Kelley Director QA/RA 300 Brickstone Square, Suite 203 Andover, MA 01810 Phone: 978-482-2309 Email: peterk@capsuletech.com | | Date Prepared | MAY 21, 2015 | | Device Name | SmartLinx Vitals Plus Patient Monitoring System | | Common Name | Physiological or Vital Signs Monitor, Patient Monitor | | Classification Name | Cardiac monitor (including cardiotachometer and rate alarm) | | Regulatory Class | II | | Product Code | MWI | | Predicate Device | GE Carescape V100 Vital Signs Monitor K102426 This predicate has not been subject to a design-related recall | | Reference Devices | Zoll R Series Monitor Defibrillators K120907 Masimo uSpO2 Pulse Oximetry Cable K121914 Exergen TAT-5000S K011291 | ## Device Description The SmartLinx Vitals Plus Patient Monitoring System consists of the SmartLinx Vitals Plus mobile medical application and externally integrated vital signs modules operating on the SmartLinx Neuron 2 mobile platform. The application controls the modules at the point of care through interfaces on the SmartLinx Neuron 2 mobile platform and presents this to the monitoring purposes. The supported physiological parameters are: non-invasive blood pressure (systolic, diastolic, mean arterial pressure (MAP)), pulse rate, functional arterial oxygen saturation (SpO2), and temperature. The SmartLinx Vitals Plus Patient Monitoring System is composed of multiple products: - The SmartLinx Vitals Plus mobile medical application - The SmartLinx Vitals Plus NIBP Module with SunTech Medical cuffs and hoses The Masimo SET uSpO2 Pulse Oximetry Cable The Exergen TAT-5000S infrared thermometer The SmartLinx Neuron 2 Mobile Platform The SmartLinx Vitals Plus Roll Stand #### SmartLinx Vitals Plus mobile medical application The SmartLinx Vitals Plus mobile medical application is a new mobile medical application which operates on the SmartLinx Neuron 2 mobile platform. It provides command/control of user features of vital signs modules, actuators and medical devices. SmartLinx Vitals Plus mobile medical application {4}------------------------------------------------ collects vital signs and medical device data at the point of care through sensor, actuator and medical device interfaces on the SmartLinx Neuron 2 mobile platform and presents this to the user for active monitoring purposes. The supported physiological parameters are: NIBP (systolic, mean arterial pressure (MAP)), Pulse Rate, SpO2 and Temperature. The SmartLinx Vitals Plus mobile medical application is used by healthcare providers. #### SmartLinx Vitals Plus NIBP Module The SmartLinx Vitals Plus NIBP Module is a new hardware component, which incorporates the SunTech Medical Advantage A+ NIBP module and associated blood pressure cuffs and hoses, which measure systolic, diastolic and mean arterial (MAP) blood pressures, and pulse rates for adult, pediatric and neonatal patients. This same module is used in the previously cleared Zoll R Series Monitor Defibrillator (K120907), which is cited as a reference device in this 510(k) filing. The module is controlled by the SmartLinx Vitals Plus mobile medical application to manage the inflation of blood pressure cuffs, and to measure blood pressures and pulse rates. The SmartLinx Vitals Plus NIBP module is used by healthcare providers. #### Masimo uSp02 Pulse Oximetry Cable The Masimo uSpO2 Pulse Oximetry Cable, and associated sensors are an in-line patient cable that provides continuous noninvasive monitoring of functional oxygen saturation (SpO2) and pulse rate when installed in a compatible OEM host system, and has its own requlatory clearance (K121914). The SmartLinx Vitals Plus application will control the uSpO2 to measure SpO2 in adult, pediatric and neonatal patients. The uSpO2 is used by healthcare providers. #### Exergen TAT-5000S The Exergen TAT-5000S is an infrared thermometer which has its own requlatory clearances (K011291). It is capable of being used independently or through an interface with other products. The SmartLinx Vitals Plus application will control the operation of the TAT-5000S to measure temperatures in adult, pediatric and neonatal patients. The TAT-5000S is used by healthcare providers. #### SmartLinx Neuron 2 Mobile Platform The SmartLinx Neuron 2 is a mobile computer which utilizes industry standard PC architecture and components, with touch-screen capabilities, and serial. USB, network and Bluetooth interfaces for device connectivity, and which runs a Microsoft Windows operating system. It provides connectivity for SmartLinx applications to vital signs modules and medical devices. #### SmartLinx Vitals Plus Roll Stand The SmartLinx Vitals Plus Roll Stand is an accessory provided to allow the users to ergonomically move and manage the SmartLinx Vitals Plus System and its components. It provides a platform for mounting the Neuron 2 and mechanical interfaces to all of the system components. ## Indications for Use The SmartLinx Vitals Plus Patient Monitoring System is intended for monitoring physiologic parameters, including non-invasive blood pressure (systolic, diastolic, and mean arterial pressure), pulse rate, functional arterial oxygen saturation (SpO2), and temperature, on adult, pediatric, and neonatal patients in healthcare facilities when used by clinical physicians or appropriate medical staff under the direction of physicians. {5}------------------------------------------------ # Comparison of the Subject and Predicate Devices | | | Table 1 Technological Characteristics Comparison | | |--|--|--------------------------------------------------|--| |--|--|--------------------------------------------------|--| | Characteristic | SmartLinx Vitals Plus | GE Carescape V100 | Discussion of Differences | | |---------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Intended Use | The SmartLinx Vitals Plus Patient Monitoring System is intended for monitoring physiologic parameters, including non-invasive blood pressure (systolic, diastolic, and mean arterial pressure), pulse rate, functional arterial oxygen saturation (SpO2), and temperature, on adult, pediatric, and neonatal patients in healthcare facilities when used by clinical physicians or appropriate medical staff under the direction of physicians. | The CARESCAPE VI00 Vital Signs Monitor is intended to monitor a single adult, pediatric or neonatal patient's vital signs at the bedside or during intra- hospital transport. Vital signs parameters include non- invasive blood pressure (systolic, diastolic, and mean arterial pressure), pulse rate, and/or oxygen saturation (pulse oximetry) and/or temperature. The portable device is designed for use in numerous clinical settings in various hospital departments such as emergency, radiology, recovery, medical/surgical, labor and delivery, endoscopy, cardiac step-down. The CARESCAPE VI00 Vital Signs Monitor can also be used in satellite areas, physicians' office, or alternate care settings. | Same | | | | Design | NIBP: Suntech Advantage A+ oscillometric OEM NIBP technology module. | NIBP: Proprietary oscillometric design. | The NIBP functions use the same mechanism of action, oscillimetry. Both devices have the same questions of safety and effectiveness regarding energy transfer to the patient. | | | | SP02: Masimo uSpO2 Oximetry Cable using SET pulse oximetry technology. | SPO2: Masimo SET pulse oximetry technology. | Same | | TEMP: Exergen TAT- 5000S temporal artery scanner thermometer | | TEMP: Exergen TAT-5000 temporal artery scanner thermometer | Same | | | Applied Part Materials | NIBP: SunTech Durable, Disposable, and Vinyl blood pressure cuffs and hoses | NIBP: GE CRITIKON Blood Pressure Cuffs and hoses | The applied parts in both devices have the same questions of safety and effectiveness regarding | | {6}------------------------------------------------ | Characteristic | SmartLinx Vitals Plus | GE Carescape V100 | Discussion of Differences | |------------------|------------------------------------------------------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | | | | biocompatibility of patient applied parts. | | | SPO2: Masimo LNCS and LNOP family of SpO2 sensors | SPO2: Masimo LNCS and LNOP family of SpO2 sensors | Same | | | TEMP: Exergen TAT- 5000S temporal artery scanner thermometer | TEMP: Exergen TAT-5000 temporal artery scanner thermometer | Same | | Energy Source | 12.6V, 2600 mAh, Lithium-Ion Battery Pack. 9V alkaline battery powers the optional Exergen TAT-5000s | 6V, 3300 mAh, sealed lead acid battery powers the main unit. A 9V alkaline battery powers the Exergen TAT-5000 | Questions of safety related to lithium ion batteries are the same as for lead acid and alkaline batteries, and thus do not raise different questions of safety and effectiveness. | #### Performance Testing Performance testing ensures that the SmartLinx Vitals Plus Patient Monitoring System performs as well as the indicated predicate device and meets all of its functional requirements and performance specifications. Safety testing assures that the device complies with applicable sections of recognized industry and safety standards. The SmartLinx Vitals Plus Patient Monitoring System performance testing is summarized in Table 2. | Category | Testing Summary | |---------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Sterilization Validation | The SmartLinx Vitals Plus Patient Monitoring System is not designed to be sterilized. | | | All patient applied parts used with the SmartLinx Vitals Plus Patient Monitoring System are sourced from the vendors of the vital signs modules. The sterilization issues related to these patient applied parts were addressed in the predicate or reference device submissions, and were cleared by FDA. | | | Shelf Life Testing | | | All patient applied parts used with the SmartLinx Vitals Plus Patient Monitoring System are sourced from the vendors of the vital signs modules. The shelf life issues related to these patient applied parts were addressed in the predicate or reference device submissions, and were cleared by FDA. | | | The SmartLinx Neuron battery has a shelf life of three months. This limit applies to batteries that are not in use. | | | The Exergen TAT-5000S uses a 9 volt alkaline battery which typically has a shelf life of seven years. | | Biocompatibility Testing | All patient applied parts used with the SmartLinx Vitals Plus Patient Monitoring System are sourced from the vendors of the vital signs modules. The biocompatibility issues related to these patient applied parts were addressed in the predicate or reference device submissions, and were cleared by FDA. | | Software Testing | Software for the SmartLinx Vitals Plus Patient Monitoring System was designed and developed in accordance with Capsule Technologie software development processes, and was verified and validated. Test results indicated that the SmartLinx Vitals Plus Patient Monitoring System complies with its predetermined specification. | | Electrical Safety | The SmartLinx Vitals Plus Patient Monitoring System was tested for patient safety in accordance with the following applicable standards: IEC 60601-1:2005 IEC 60601-1-6:2013 IEC 60601-1-8:2012 IEC 80601-2-30:2013 ISO 80601-2-56:2009 ISO 80601-2-61:2011 ISO 81060-2:2013 IEC 62304:2006 IEC 62366:2014 IEC 62133:2012 Test results indicated that the SmartLinx Vitals Plus Patient Monitoring System complies with its predetermined specification. | | Electromagnetic Compatibility Testing | The SmartLinx Vitals Plus Patient Monitoring System was tested for EMC in accordance with IEC 60601-1-2:2007. Test results indicated that the SmartLinx Vitals Plus Patient Monitoring System complies with its predetermined specification. | | Performance Testing - Bench | The SmartLinx Vitals Plus Patient Monitoring System was tested in accordance with internal Capsule Technologie requirements and procedures. Test results indicated that the SmartLinx Vitals Plus Patient Monitoring System complies with its predetermined specification. This testing includes performance, functional, reliability, environmental, and packaging testing . | | Performance Testing - Animal | Animal performance testing was not performed and is not necessary to demonstrate safety and effectiveness of the SmartLinx Vitals Plus Patient Monitoring System. | | Performance Testing - Clinical | The SmartLinx Vitals Plus Patient Monitoring System was tested for clinical performance in accordance with the following applicable standard: ISO 81060-2:2013 Test results indicated that the SmartLinx Vitals Plus Patient Monitoring System complies with its predetermined specification. | Table 2 SmartLinx Vitals Plus Patient Monitoring System Performance Testing {7}------------------------------------------------ {8}------------------------------------------------ ## Conclusions Capsule Technologie SAS considers the SmartLinx Vitals Plus Patient Monitoring System to be as safe, as effective, and its performance is substantially equivalent to the predicate device.

SmartLinx Vitals Plus Patient Monitoring System

Device Facts

Indications for Use

Device Story

Clinical Evidence

Technological Characteristics

Indications for Use

Regulatory Classification

Identification

Predicate Devices

Reference Devices

Submission Summary (Full Text)

Panel 1

Section Matches

Product Code Matches

Special Control Matches

My Alerts

SmartLinx Vitals Plus Patient Monitoring System

Device Facts

Indications for Use

Device Story

Clinical Evidence

Technological Characteristics

Indications for Use

Regulatory Classification

Identification

Predicate Devices

Reference Devices

Submission Summary (Full Text)

Panel 1

Section Matches

Product Code Matches

Special Control Matches

My Alerts

Create Alert

Search Filters

Agent Token

Connected apps

Welcome

Check your email

Welcome!